"Please do not call our hospitals or your doctor's office to schedule a COVID-19 vaccination. We're following CDC and state guidelines with a phased approach that prioritizes those most vulnerable. If you're our patient, we'll email, call or text you directly to schedule your vaccination when you become eligible and it's your turn to get vaccinated based on available supplies."

During the past decade, Aurora West Allis Medical Center conducted 120 clinical trials. In the 10-year time frame, 120 clinical trials started and 88 clinical trials were completed, i.e. on average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 57 clinical trials were completed. i.e. 211.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aurora West Allis Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 86 trials, followed by "SWOG Cancer Research Network" with 31 trials sponsored, "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "NRG Oncology" with 19 trials sponsored and "Radiation Therapy Oncology Group" with 19 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aurora West Allis Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 129 trials as a collaborator, "NRG Oncology" with 42 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "Genentech, Inc." with 4 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Aurora West Allis Medical Center" are "Recurrent Ovarian Carcinoma" (14 trials), "Invasive Breast Carcinoma" (9 trials), "Primary Peritoneal Serous Adenocarcinoma" (9 trials), "Recurrent Fallopian Tube Carcinoma" (9 trials) and "Recurrent Squamous Cell Lung Carcinoma" (9 trials). Many other conditions were trialed in "Aurora West Allis Medical Center" in a lesser frequency.

Most popular intervention types in "Aurora West Allis Medical Center" are "Drug" (166 trials), "Other" (141 trials), "Biological" (74 trials), "Procedure" (59 trials) and "Radiation" (57 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (72 trials), "Laboratory Biomarker Analysis" (66 trials), "Questionnaire Administration" (41 trials), "Paclitaxel" (31 trials) and "Carboplatin" (29 trials). Other intervention names were less common.

The vast majority of trials in "Aurora West Allis Medical Center" are 138 trials for "All" genders, 69 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "Aurora West Allis Medical Center". undefined are not yet recruiting, 50 are recruiting, 110 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Aurora West Allis Medical Center, 6 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Aurora West Allis Medical Center, 3 "Phase 1" clinical trials were conducted, 89 "Phase 2" clinical trials and 131 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 13 trials that are defined as “Not Applicable".